Showing results (131-140 of 177) with videos related to
Sort By:
Pageof 18
Blood|June 1, 1997
Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group StudyM J Borowitz, J Shuster, A J Carroll, et al.Plos One|March 9, 2010
Impaired glucose tolerance in sleep disordersMarietta Keckeis, Zuzana Lattova, Eszter Maurovich-Horvat, et al.Journal of STEM Outreach|February 17, 2022
STEM Through Authentic Research and Training Program (START) for Underrepresented Communities: Adapting to the COVID-19 PandemicLuke H Bradley, Brittany N Derr, Catherine E Durbin, et al.Journal of Pediatric Hematology/Oncology|March 3, 2011
Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology GroupWanda L Salzer, Naomi J Winick, Pierre Wacker, et al.Journal of Pediatric Psychology|October 23, 1998
Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxisR T Brown, A Madan-Swain, G A Walco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.Journal of Pediatric Hematology/Oncology|June 17, 1998
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot StudyS J Lauer, B M Camitta, B G Leventhal, et al.International Journal of Molecular Sciences|July 28, 2022
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of PatientsJonas Feldheim, David Wend, Mara J Lauer, et al.Leukemia|July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialS J Lauer, J J Shuster, D H Mahoney, et al.Journal of Electrocardiology|November 13, 2007
An algorithm for QT interval monitoring in neonatal intensive care unitsEric D Helfenbein, Michael J Ackerman, Pentti M Rautaharju, et al.Pageof 18